A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer

Clinical trial NCT00994123 · COMPLETED

Trial details

NCT number: NCT00994123
Sponsor: Merrimack Pharmaceuticals
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Carcinoma, Non-Small-Cell Lung

Start date: 2010-02-01
Primary completion: 2014-11-01
Enrollment: 162

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.